| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/29/2004 | CA2497313A1 Biomolecule transfer method using virus envelope and composition and system therefor |
| 04/28/2004 | EP1413583A2 Compounds that inhibit T cell proliferation and methods using the same |
| 04/28/2004 | EP1413576A2 Substituted imidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors |
| 04/28/2004 | EP1413314A1 Medicinal compositions |
| 04/28/2004 | EP1413307A1 Therapeutically active levorotatory and dextrorotatory 1-(4-chlorophenyl)phenylmethyl piperazines |
| 04/28/2004 | EP1413299A2 Use of deprenyl analogues to maintain, prevent loss, or recover nerve cell function |
| 04/28/2004 | EP1413295A1 Sustained release composition for oral administration of drugs |
| 04/28/2004 | EP1412515A2 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 04/28/2004 | EP1412492A2 Regulator of calcineurin |
| 04/28/2004 | EP1412386A2 USE OF PEPTIDE FRAGMENTS OF THE CALCIUM CHANNEL $g(A)-1 SUBUNIT, OPTIONALLY COMPRISING MUTATIONS, FOR SCREENING MOLECULES OF THERAPEUTIC INTEREST |
| 04/28/2004 | EP1412371A1 IN VIVO PRODUCTION OF SMALL INTERFERING RNAs THAT MEDIATE GENE SILENCING |
| 04/28/2004 | EP1412368A2 Sugar derivatives of hydromorphone, dihydromorphine and dihydroisomorphine, compositions thereof and uses for treating or preventing pain |
| 04/28/2004 | EP1412363A1 Gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1412361A1 Substituted 5,6,6a,11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid derivatives serving as nmda antagonists |
| 04/28/2004 | EP1412357A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/28/2004 | EP1412354A1 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A 2a? RECEPTOR AND THEIR USE AS MEDICAMENTS |
| 04/28/2004 | EP1412352A1 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands |
| 04/28/2004 | EP1412341A1 Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r- and s-citalopram |
| 04/28/2004 | EP1412340A2 Process for the preparation of citalopram hydrobromide |
| 04/28/2004 | EP1412338A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1412330A1 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/28/2004 | EP1412327A2 Inhibitors of protein kinase for the treatment of disease |
| 04/28/2004 | EP1412325A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 04/28/2004 | EP1412324A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 04/28/2004 | EP1412028A1 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 04/28/2004 | EP1411968A2 Glp-1 exendin-4 peptide analogs and uses thereof |
| 04/28/2004 | EP1411966A2 Method for treating secondary tissue degeneration associated with central nervous system injury |
| 04/28/2004 | EP1411948A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 04/28/2004 | EP1411947A2 Salts of substituted 1, 2, 3, 4-tetrahydroisoquinoline-2-carboxylic acid derivatives |
| 04/28/2004 | EP1411946A1 Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses |
| 04/28/2004 | EP1411945A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1411944A1 Sulfonamide derivatives as gamma secretase inhibitors |
| 04/28/2004 | EP1411943A2 Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidate |
| 04/28/2004 | EP1411942A1 Substituted anilinic piperidines as mch selective antagonists |
| 04/28/2004 | EP1411941A2 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1411939A2 Gaba a-receptor-modulators having nmda-antagonistic activity |
| 04/28/2004 | EP1411934A1 Treatment of chronic pain with 3-heterocyclyl- and 3-cycloalkyl-3-aryloxypropanamines |
| 04/28/2004 | EP1411931A1 Zonisamide use in headache |
| 04/28/2004 | EP1411925A1 5-arylsulfonyl indoles having 5-ht6 receptor affinity |
| 04/28/2004 | EP1411917A1 Carbamate compounds for use in preventing or treating movement disorders |
| 04/28/2004 | EP1411912A1 Treatment of chronic pain with 3-aryloxy-3-phenylpropanamines |
| 04/28/2004 | EP1411910A1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 04/28/2004 | EP1411899A2 Taste masking composition |
| 04/28/2004 | EP1411898A1 Pharmaceutical composition comprising lipids with a polar and a nonpolar moiety |
| 04/28/2004 | EP1411881A2 5HT sb 2C /sb RECEPTOR MODULATORS |
| 04/28/2004 | EP1411879A1 A composition and uses therefor for combating hangover |
| 04/28/2004 | EP1326628B1 Chemokine mutants in the treatment of multiple sclerosis |
| 04/28/2004 | EP1289986B1 1,4-diazabicyclo 3.2.2]nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof |
| 04/28/2004 | EP1280760B1 Novel spiro[2.4]heptane amino carboxy compounds and derivatives thereof |
| 04/28/2004 | EP1263718B1 Novel use of phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1263715B1 Novel phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1263714B1 Novel phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1227098B1 Triazolopurine derivatives, drug compositions containing the same and adenosine a3 receptor affinitive agents |
| 04/28/2004 | EP1206448B1 Novel vitamin d analogues |
| 04/28/2004 | EP1154983B1 Novel substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines |
| 04/28/2004 | EP1137631B1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE |
| 04/28/2004 | EP1087970B1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/28/2004 | EP1042313B1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity |
| 04/28/2004 | EP0937045B1 N-aryl substituted tetrahydroquinolines ligands for retinoid receptors having agonist, antagonist or inverse agonist type activity |
| 04/28/2004 | EP0915842B1 Nitrate esters and their use for neurological conditions |
| 04/28/2004 | EP0912174B1 Alteration of circadian rhythmicity with non-peptidal neurikinin-1 receptor antagonists |
| 04/28/2004 | EP0885309B1 Direct molecular diagnosis of friedreich ataxia |
| 04/28/2004 | EP0782857B1 use of 4-acylaminopyridine derivatives in the manufacture of a medicament for treating cerebrovascular disorders |
| 04/28/2004 | EP0719253B1 3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists |
| 04/28/2004 | CN1492926A Preferred segments of neural thread protein and methods of using the same |
| 04/28/2004 | CN1492879A Protein tau |
| 04/28/2004 | CN1492871A Isoxazoline derivatives as anti-depressants |
| 04/28/2004 | CN1492863A Heterocyclylalkylindole or azaindole compounds as 5-hydroxytryptamine-6 ligands |
| 04/28/2004 | CN1492861A Process for preparation of citalopram |
| 04/28/2004 | CN1492856A Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 04/28/2004 | CN1492765A Herbal composition for preventing and treatment of dementia |
| 04/28/2004 | CN1492737A Functional agent for decomposing nicotine and method of preparing the same |
| 04/28/2004 | CN1491963A Live scorpion active protein having anti-epilepsy function, preparing method and use |
| 04/28/2004 | CN1491713A Chinese medicine compound preparation for treating depression |
| 04/28/2004 | CN1491706A Soft capsule for removing blood stasis in chest and its preparing method |
| 04/28/2004 | CN1491701A Medicine for treating sympthetic nerve disorder |
| 04/28/2004 | CN1491693A Extraction of wild jujube seed oil and preparation of soft capsule and function on central nervous system |
| 04/28/2004 | CN1491687A Medicine for treating epilepsy |
| 04/28/2004 | CN1491686A Chinese medicine preparation for sobering up and liver protection and its preparing method |
| 04/28/2004 | CN1147494C Novel benzodiazine compound, its preparation method and medicine composition containing them |
| 04/28/2004 | CN1147490C Furanotetrapyridine derivatives and its medicinal compounds and their use in the treatment of neurodegenerative disease |
| 04/28/2004 | CN1147482C Substittued (dihydro) benzoxazole and (dihydro)benzoxazine compound and its preparation and medicine composite |
| 04/28/2004 | CN1147481C Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 04/28/2004 | CN1147476C Pyrazole derivatives as P-38 MAP kinase inhibitors |
| 04/28/2004 | CN1147470C Novel 2,3,3A,4,9,9A hexahydro-8-hydroxy-1H-benz[f] indoles, a method for the production thereof, and their use as medicine |
| 04/28/2004 | CN1147461C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
| 04/28/2004 | CN1147329C Device for trandermal electrotransport delivery of fentanyl and sufentanil |
| 04/28/2004 | CN1147299C Indole-3-propionic acids, salts and esters thereof used as medicaments |
| 04/28/2004 | CN1147296C Preparation method of medicine for resisting ischemic and brain trauma using taurine |
| 04/28/2004 | CN1147295C Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof and its preparation |
| 04/27/2004 | US6727363 From toluene/diethyl ether mixture; recovering, drying |
| 04/27/2004 | US6727353 Nucleic acid encoding Kv10.1, a voltage-gated potassium channel from human brain |
| 04/27/2004 | US6727281 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
| 04/27/2004 | US6727279 Central nervous system disorders |
| 04/27/2004 | US6727275 Pyrrolidinone derivatives |
| 04/27/2004 | US6727274 Use in treating conditions in which 5-ht6 receptors are involved such as anxiety, depression, schizophrenia, alzheimer's disease, stress-related disease, nervous system disorders; use in performing positron emission tomography |
| 04/27/2004 | US6727273 Therapy for osteoporosis, anticancer agents |
| 04/27/2004 | US6727270 Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands |
| 04/27/2004 | US6727269 Acromegaly, pituitary adenoma or endocrine gastroenteropanceatic tumors including the carcinoid syndrome, and gastrointestinal bleeding |
| 04/27/2004 | US6727268 Cyclooxygenase inhibitors; antipyretic, analgesic, antiinflammatory, and anticarcinogenic agents |